Vijay Singh Gondil (Sanjay Chhibber)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Silver Nanoparticles

Methicillin Resistant Staphylococcus Aureus

Cystic Fibrosis

Multidrug Resistant

Top Venues

Antibiotics (Basel, Switzerland)

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Preeti Negi, Kusum Harjai, Kusum Harjai, Vijay Singh Gondil, Seema Kumari, Khem Raj
Antimicrobial and Antibiofilm Potential of Green-Synthesized Graphene-Silver Nanocomposite against Multidrug-Resistant Nosocomial Pathogens. Biomedicines 12 (5) (2024)
Preeti Negi, Kusum Harjai, Kusum Harjai, Vijay Singh Gondil, Seema Kumari, Khem Raj
Antimicrobial and Antibiofilm Potential of Green-Synthesized Graphene-Silver Nanocomposite against Multidrug-Resistant Nosocomial Pathogens. Biomedicines 12 (5) (2024)
Fazal Mehmood Khan, Prasanth Manohar, Vijay Singh Gondil, Nancy Mehra, Greater Kayode Oyejobi, Nelson Odiwuor, Tauseef Ahmad, Guangtao Huang
The applications of animal models in phage therapy: An update. Human vaccines & immunotherapeutics (2023)
Mikaeel Young, Danica J Walsh, Elysia Masters, Vijay Singh Gondil, Emily Laskey, Michael E Klaczko, Hani A Awad, James McGrath, Edward M Schwarz, Christian Melander, Paul M Dunman
Identification of Staphylococcus aureus Penicillin Binding Protein 4 (PBP4) Inhibitors. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Vijay Singh Gondil, Thiyagarajan Kalaiyarasan, Vijay K Bharti, Vijay Singh Gondil
Antibiofilm potential of Seabuckthorn silver nanoparticles (SBT@AgNPs) against Pseudomonas aeruginosa. 3 Biotech 9 (11) (2019)